Tove C Bolken

This inventor holds 24 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Antiviral Drug Development. Top assignees: Siga Technologies Inc., Kineta Four, LLC, Kineta, Inc.. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tove C Bolken. Retrieved from https://idiyas.com/inventor/tove-c-bolken

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 3)

% Patents Active = 16.7

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 38(Granted Patents)

Location History:

Jefferson, OR (US) (2006)
N. Keizer, OR (US) (2014 - 2015)
Keizer, OR (US) (2011 - 2020)

Company Filing History:

20 out of 58

Siga Technologies Inc.

Years Active: 2006-2020

Loading Chart...

Areas of Expertise:

Antiviral Drugs

Dengue Infection

Arenavirus Treatment

Pharmaceutical Compositions

Hemorrhagic Fever

Sulfonyl Semicarbazides

Anti-Arenaviral Compounds

Liquid Formulations

Infection Prevention

Screening Methods

Orthopoxvirus Antivirals

Drug Formulations

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10864282 - ST-246 liquid formulations and methods (2020-12-15),

2. 10576165 - ST-246 liquid formulations and methods (2020-03-03),

3. 10124071 - ST-246 liquid formulations and methods (2018-11-13),

4. 9353051 - Antiviral drugs for treatment or prevention of dengue infection (2016-05-31),

5. 9233097 - ST-246 liquid formulations (2016-01-12),

6. 9199920 - Antiviral drugs for treatment of arenavirus infection (2015-12-01),

7. 9115065 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses (2015-08-25),

8. 9096597 - Antiviral drugs for treatment of Arenavirus infection (2015-08-04),

9. 8871746 - Antiviral drugs for treatment of arenavirus infection (2014-10-28),

10. 8791110 - Anti-arenaviral compounds (2014-07-29),

11. 8754082 - [object Object] (2014-06-17),

12. 8664274 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses (2014-03-04),

13. 8658697 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses (2014-02-25),

14. 8629170 - Anti-viral drugs for treatment of arenavirus infection (2014-01-14),

15. 8623347 - Antiviral drugs for treatment of arenavirus infection (2014-01-07),

Title: Tove C. Bolken: Pioneering Innovator in Pharmaceuticals

Introduction:

Meet Tove C. Bolken, a renowned inventor based in Keizer, Oregon, with an impressive track record of 24 patents to his name. Bolken is a visionary in the field of pharmaceuticals, consistently pushing the boundaries of innovation in medicine.

Latest Patents:

Bolken's latest groundbreaking patents include the development of ST-246 liquid formulations and methods. These patents showcase his ingenuity in creating novel liquid formulations for solubilizing poorly soluble ST-246 in cyclodextrins, along with a revolutionary process for manufacturing these formulations.

Career Highlights:

Throughout his career, Bolken has made significant contributions to the pharmaceutical industry. Notably, he has lent his expertise to companies such as Siga Technologies Inc. and Kineta Four, LLC, where his innovative work has left a lasting impact on the field.

Collaborations:

Bolken has had the privilege of collaborating with esteemed professionals in the industry, including Dennis E. Hruby and Dongcheng Dai. Together, they have worked on pioneering projects that have reshaped the landscape of pharmaceutical innovation.

Conclusion:

In conclusion, Tove C. Bolken stands as a trailblazer in the world of pharmaceutical inventions, with a remarkable portfolio of patents that reflect his unwavering commitment to driving innovation forward. His groundbreaking work continues to inspire and shape the future of medicine.

Profile summary based on public USPTO records.